PTEN1 is frequently mutated in primary endometrial carcinomas-Reference-Cited by-同舟云学术

PTEN1 is frequently mutated in primary endometrial carcinomas

Published:1997-10 Issue:2 Volume:17 Page:143-144
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Kong Dehe,Suzuki Akihiko,Zou Tong-Tong,Sakurada Akira,Kemp Lawrence W.,Wakatsuki Shigeru,Yokoyama Tadaaki,Yamakawa Hiromitsu,Furukawa Toru,Sato Masami,Ohuchi Noriaki,Sato Shinji,Yin Jing,Wang Suna,Abraham John M.,Souza Rhonda F.,Smolinski Kara N.,Meltzer Stephen J.,Horii Akira

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1097-143.pdf

Reference12 articles.

1. Robboy, S.J. et al. in Essential Pathology (eds Rubin, E . & Farber, J.L) 516–525 (J.B. Lippincott, Philadelphia, 1995).

2. Fujimoto, I. et al. in Cancer Incidence and Mortality Statistics in Osaka, 1963–1989 (eds Fujimoto, I. et al) 49–214 (Shinohara, Osaka, Japan, 1993).

3. Okamoto, A. et al. Cancer Res. 51, 5632–5635 (1991).

4. Enomoto, T. et al. Cancer Res. 50, 6139–6145 (1990).

5. Li, J. et al. Science 275, 1943–1947 (1997).

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer;Cancer Treatment Reviews;2024-05

2. Obesity-Induced Leptin-Signaling Pathways to Gynecologic Cancers;Obesity;2024

3. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling;Biomedicine & Pharmacotherapy;2023-12

4. In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers;Advanced Science;2023-09-25

5. Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer;Experimental Cell Research;2023-09